title: The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte response.
abstract: Cytotoxic T lymphocyte (CTL) response is a critical component of the immune response to tumors, therefore optimal induction of CTL responses to tumor antigens is highly desired for developing efficient cancer immunotherapy. IL-27 is a member of the IL-12 family of cytokines that is comprised of an IL-12 p40-related protein subunit, EBV-induced gene 3 (EBI3), and a p35-related subunit, p28. IL-27 functions through IL-27R and has been shown to have potent anti-tumor activity via activation of a variety of immune components, including anti-tumor CD8(+) T cell responses. However, the exact mechanisms of how IL-27 enhances anti-tumor CD8(+) T cell responses are not fully understood. In this paper we mainly discuss the evidences that suggest novel mechanisms by which IL-27 enhances anti-tumor CTL responses, including IL-27 inhibition of activation-induced cell death; the phenotypes of IL-27-stimulated CTLs; IL-27-induced CTL IL-10/IL-21 production and IL-27-mediated suppression of regulatory T cell responses. These evidences suggest that IL-27 may have a great potential to be utilized in boosting anti-tumor CTL responses in human cancer patients.
authors: Department of Pathology and Comprehensive Cancer Center, The Ohio State University Columbus, OH, USA.
authors: Zhenzhen
authors: Z
authors: Liu
authors: Jianhua
authors: J
authors: Yu
authors: William E
authors: WE
authors: Carson
authors: Xue-Feng
authors: XF
authors: Bai
keywords: IL-21; IL-27; anti-tumor cytotoxic T lymphocyte (CTLs); cancer; p28; p35; p53
references: Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15047-52
references: 14657353
references: J Immunol. 2009 Nov 15;183(10):6217-26
references: 19841177
references: Adv Immunol. 2012;115:1-44
references: 22608254
references: Eur J Immunol. 2011 Jan;41(1):47-59
references: 21182076
references: J Exp Med. 2011 May 9;208(5):1001-13
references: 21518797
references: J Immunol. 1995 Sep 15;155(6):3112-23
references: 7673726
references: Immunity. 2002 Jun;16(6):779-90
references: 12121660
references: Nature. 2006 Feb 9;439(7077):682-7
references: 16382236
references: J Immunol. 2009 Jul 15;183(2):797-801
references: 19570826
references: Immunity. 2012 Dec 14;37(6):960-9
references: 23244718
references: Cancer Res. 2012 Jan 15;72(2):420-9
references: 22123924
references: J Immunol. 1996 Jul 1;157(1):231-8
references: 8683120
references: J Immunol. 2005 Aug 1;175(3):1686-93
references: 16034109
references: J Biomed Biotechnol. 2010;2010:605483
references: 20454646
references: J Immunol. 2013 Feb 15;190(4):1510-8
references: 23335749
references: J Exp Med. 2010 Dec 20;207(13):2895-906
references: 21098093
references: Science. 1992 Aug 7;257(5071):809-13
references: 1496401
references: Nat Med. 2004 Sep;10(9):909-15
references: 15340416
references: J Immunol. 2004 Dec 15;173(12):7170-82
references: 15585838
references: Cancer Res. 2006 Jun 15;66(12):6395-404
references: 16778218
references: Science. 2009 Jun 19;324(5934):1572-6
references: 19443735
references: J Immunol. 2011 Jul 1;187(1):266-73
references: 21622862
references: J Immunol. 2007 Sep 1;179(5):3268-75
references: 17709543
references: J Immunol. 2012 Apr 1;188(7):3099-106
references: 22387555
references: Clin Cancer Res. 2007 Aug 15;13(16):4677-85
references: 17699845
references: J Immunol. 2009 May 1;182(9):5748-56
references: 19380822
references: Blood. 2007 May 15;109(10):4135-42
references: 17234735
references: J Immunol. 2006 Dec 1;177(11):7515-9
references: 17114419
references: J Mol Med (Berl). 2007 Jul;85(7):661-72
references: 17294231
references: Science. 2009 Jun 19;324(5934):1569-72
references: 19423777
references: J Immunol. 2006 Oct 15;177(8):5377-85
references: 17015723
references: Science. 2009 Jun 19;324(5934):1576-80
references: 19478140
references: J Immunol. 2010 Oct 15;185(8):4835-45
references: 20844201
references: Mol Ther. 2003 Oct;8(4):552-8
references: 14529827
references: J Immunol. 2005 Mar 15;174(6):3534-44
references: 15749890
references: Nat Med. 2009 Jul;15(7):808-13
references: 19525962
references: PLoS One. 2013;8(3):e57469
references: 23554861
references: J Pathol. 2004 Feb;202(2):164-71
references: 14743498
references: J Clin Invest. 2012 Apr;122(4):1271-82
references: 22426209
references: J Immunol. 2008 May 15;180(10):6527-35
references: 18453571
references: Eur J Immunol. 2013 Feb;43(2):468-79
references: 23225163
references: Z Ernahrungswiss. 1998;37 Suppl 1:43-9
references: 9558728
references: J Immunol. 2004 Feb 1;172(3):1540-7
references: 14734732
references: J Immunol. 2010 Mar 1;184(5):2348-54
references: 20139275
references: Nat Immunol. 2007 Dec;8(12):1363-71
references: 17994025
references: Int J Cancer. 2009 Mar 15;124(6):1372-8
references: 19089917
references: Immunity. 2011 Nov 23;35(5):792-805
references: 22118527
references: Immunity. 2012 Sep 21;37(3):511-23
references: 22981537
references: Science. 1994 Jan 7;263(5143):92-5
references: 8272873
references: J Immunol. 2006 May 15;176(10):6347-55
references: 16670347
references: Curr Mol Med. 2008 Feb;8(1):68-75
references: 18289015
references: Immunol Cell Biol. 2012 Sep;90(8):831-5
references: 22430249
references: Immunity. 2012 Jun 29;36(6):1017-30
references: 22726954
references: Clin Cancer Res. 2010 Aug 15;16(16):4188-97
references: 20587591
references: Brain Res. 2005 Apr 8;1040(1-2):202-7
references: 15804443
references: J Immunol. 2011 Mar 15;186(6):3642-52
references: 21317392
references: Mol Immunol. 2013 Oct;55(3-4):264-74
references: 23522926
references: Biochem Biophys Res Commun. 2005 Jan 28;326(4):724-8
references: 15607729
references: J Immunol. 2006 Jun 15;176(12):7317-24
references: 16751375
references: Trends Mol Med. 2013 Feb;19(2):108-16
references: 23306374
references: Nat Med. 2005 Dec;11(12):1299-305
references: 16288282
references: Cancer Cell. 2011 Dec 13;20(6):781-96
references: 22172723
references: Nat Immunol. 2010 Sep;11(9):854-61
references: 20676095
references: Immunity. 2003 Nov;19(5):657-67
references: 14614853
references: Blood. 2006 Jun 1;107(11):4475-83
references: 16467201
references: Cancer Res. 2004 Feb 1;64(3):1152-6
references: 14871851
references: J Immunol. 2004 Sep 15;173(6):3871-7
references: 15356135
references: Int Immunol. 2008 Feb;20(2):223-34
references: 18156621
references: Cancer Res. 2009 Mar 15;69(6):2523-30
references: 19244121
references: J Immunol. 2003 May 15;170(10):4886-90
references: 12734330
references: Immunity. 2011 Nov 23;35(5):806-18
references: 22118528
references: J Clin Invest. 2011 Dec;121(12):4746-57
references: 22056381
references: J Immunol. 2003 Jul 15;171(2):608-15
references: 12847225
references: Blood. 2008 Jun 1;111(11):5326-33
references: 18276844
references: J Immunol. 2006 Aug 15;177(4):2565-74
references: 16888018
references: J Biol Chem. 2007 Nov 30;282(48):34605-10
references: 17884812
references: Nature. 2000 Oct 19;407(6806):916-20
references: 11057672
references: Anticancer Res. 2004 Nov-Dec;24(6):3763-7
references: 15736409
references: J Exp Med. 2012 Oct 22;209(11):2113-26
references: 23008334
references: Science. 1992 Dec 11;258(5089):1808-12
references: 1281555
references: Nat Immunol. 2007 Dec;8(12):1380-9
references: 17994022
references: J Immunol. 2009 May 15;182(10):6226-36
references: 19414776
references: Annu Rev Immunol. 2008;26:57-79
references: 17953510
references: J Immunol. 2008 Mar 1;180(5):2752-6
references: 18292493
references: Nat Rev Immunol. 2005 Sep;5(9):688-98
references: 16138102
references: J Immunol. 2004 Feb 15;172(4):2225-31
references: 14764690
references: Cytokine Growth Factor Rev. 2002 Apr;13(2):155-68
references: 11900991
references: J Exp Med. 2013 Apr 8;210(4):743-55
references: 23547098
references: Curr Opin Immunol. 2012 Apr;24(2):207-12
references: 22236695
references: J Immunol. 1999 Feb 1;162(3):1723-9
references: 9973435
references: J Exp Med. 2011 Jan 17;208(1):115-23
references: 21173106
references: Int J Cancer. 2005 Jun 20;115(3):437-42
references: 15688376
references: J Immunol. 2009 Apr 1;182(7):4328-38
references: 19299733
references: Eur J Immunol. 2007 Jul;37(7):1809-16
references: 17549733